A salidroside-mediated injectable hydrogel microsphere combining immunomodulatory and reactive oxygen species scavenging for delaying intervertebral disc degeneration
Source abstract
Abstract
Intervertebral disc degeneration (IVDD)-associated low back pain represents a substantial global health challenge with profound socioeconomic consequences. The dysregulated immune microenvironment in degenerated discs creates a hostile milieu that suppresses tissue repair. In this study, we engineered a hierarchical delivery platform where salidroside (SAL)-functionalized Prussian blue analogues (PBA) were electrostatically assembled into gelatin methacryloyl (GelMA) hydrogel microspheres. The system enables spatiotemporally controlled SAL release by combining PBA-mediated molecular loading with GelMA microsphere-based sustained delivery reservoirs. These functionalized hydrogel microspheres serve as fundamental regulatory units for the IVDD immune microenvironment, enabling minimally invasive treatment of IVDD. In vitro experiments revealed that functionalized hydrogel microspheres effectively promoted the activation of macrophages towards the reparative sentinel M2 phenotype, scavenged reactive oxygen species (ROS), and improved extracellular matrix (ECM) metabolism. In vivo studies further revealed that the functionalized hydrogel microspheres significantly restored intervertebral disc height, water content, and tissue structure in a rat IVDD model, while also enhancing ECM repair and suppressing inflammation. This study provides a novel therapeutic strategy for immunomodulation and tissue repair in degenerative disc diseases, with potential for future clinical translation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Medicinal Plants and Bioactive Compounds · Spine and Intervertebral Disc Pathology · Medical and Biological Ozone Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Treatment of Low Back Pain10.1001/jama.2017.9386 ↗
2. A novel nomogram for the early identification of coinfections in elderly patients with coronavirus disease 201910.1186/s12985-025-02854-z ↗
3. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021, Lancet
4. Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions10.1038/s41413-020-00125-x ↗
5. Discogenic Low Back Pain: Anatomy, Pathophysiology and Treatments of Intervertebral Disc Degeneration10.3390/ijms24010208 ↗
6. Mechanical damage to the intervertebral disc annulus fibrosus subjected to tensile loading10.1016/j.jbiomech.2004.03.038 ↗
7. The role of the nucleus pulposus in intervertebral disc recovery: Towards improved specifications for nucleus replacement devices10.1016/j.jbiomech.2024.111990 ↗
8. Achilles’ Heel—The significance of Maintaining Microenvironmental Homeostasis in the Nucleus Pulposus for Intervertebral Discs10.3390/ijms242316592 ↗
9. The pathogenesis and targeted therapies of intervertebral disc degeneration induced by cartilage endplate inflammation10.3389/fcell.2024.1492870 ↗
10. Altered Metabolism and Inflammation Driven by Post-translational modifications in Intervertebral Disc Degeneration10.34133/research.0350 ↗
11. The involvement of immune system in intervertebral disc herniation and degeneration10.1002/jsp2.1196 ↗
12. Cytochrome c oxidase dysfunction enhances phagocytic function and osteoclast formation in macrophages10.1096/fj.201900010RR ↗
13. The Immune Privilege of the Intervertebral Disc: Implications for Intervertebral Disc Degeneration Treatment10.7150/ijms.42238 ↗
14. A new immunometabolic perspective of intervertebral disc degeneration10.1038/s41584-021-00713-z ↗
15. How Mouse Macrophages sense what is going on10.3389/fimmu.2016.00204 ↗
16. Exosomes derived from reparative M2-like macrophages prevent bone loss in murine periodontitis models via IL-10 mRNA10.1186/s12951-022-01314-y ↗
17. M2 Macrophage‐Derived sEV Regulate Pro‐Inflammatory CCR2+ Macrophage Subpopulations to Favor Post‐AMI Cardiac Repair
18. An overview on natural product drug formulations from conventional medicines to nanomedicines: past, present and future
19. Effects of traditional chinese medicine polysaccharides on chronic diseases by modulating gut microbiota: a review
20. Chinese herb-crosslinked polysaccharide hydrogel loading DFO accelerates diabetes wound healing10.1016/j.matdes.2025.114128 ↗
21. Research progress on antiviral constituents in traditional chinese medicines and their mechanisms of action10.1080/13880209.2022.2074053 ↗
22. Anti-tumor and immunomodulatory activity of peptide fraction from the larvae of Musca domestica10.1016/j.jep.2014.03.052 ↗
23. Biosynthesis and biotechnological production of salidroside from Rhodiola genus plants10.1007/s11101-021-09800-1 ↗
24. Salidroside in the Treatment of NAFLD/NASH10.1002/cbdv.202200401 ↗
25. Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice10.1016/j.biopha.2020.111137 ↗
26. Salidroside Regulates Mitochondrial Homeostasis after Polarization of RAW264.7 Macrophages10.1097/FJC.0000000000001362 ↗
27. Salidroside ameliorated the pulmonary inflammation induced by cigarette smoke via mitigating M1 macrophage polarization by JNK / c‐Jun10.1002/ptr.7905 ↗
28. Multiple nano-drug delivery systems for intervertebral disc degeneration: current status and future perspectives
29. Exploration of glassy state in Prussian blue analogues10.1038/s41467-022-31658-w ↗
30. Nanosized Prussian blue and its analogs for bioimaging and cancer theranostics10.1016/j.actbio.2023.12.047 ↗
31. PEGMA-modified bimetallic NiCo Prussian blue analogue doped with Tb(III) ions: Efficiently pH-responsive and controlled release system for anticancer drug10.1016/j.cej.2020.124468 ↗
32. Tunable Hollow Bimetallic MnFe Prussian Blue Analogue as the Targeted pH-responsive delivery System for Anticancer Drugs10.1021/acsabm.9b00129 ↗
33. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis10.1186/s12951-021-00897-2 ↗
34. Dynamic Schiff base linkage-based double-network hydrogels with injectable, self-healing, and pH-responsive properties for bacteria-infected wound healing10.1007/s10570-024-05972-z ↗
35. Photothermally enhanced antibacterial and antioxidant dextran hydrogel dressing incorporating tannic acid microparticles for accelerated wound healing10.1016/j.ijbiomac.2025.148849 ↗
36. Precise Lubrication and Protection of Cartilage damage by Targeting Hydrogel Microsphere10.1002/adma.202405943 ↗
37. Spatiotemporalized Hydrogel Microspheres Promote Vascularized Osteogenesis via Ultrasound Oxygen delivery
38. Immunomodulatory exosomes loaded chitosan methacryloyl hydrogel combined with pro-chondrogenic microspheres for promoting articular cartilage regeneration10.1016/j.matdes.2025.113876 ↗
39. Biomimetic Methacrylated Gelatin Hydrogel Loaded with Bone Marrow Mesenchymal Stem Cells for Bone Tissue Regeneration10.3389/fbioe.2021.770049 ↗
40. Metalloproteinase-responsive gelatin/polylysine hydrogel microneedles for on-demand curcumin delivery in bacteria-infected wound healing10.1016/j.colsurfb.2025.114797 ↗
41. GsMTx4-loaded GelMA promotes tendon regeneration and suppresses heterotopic ossification via the Apelin signaling pathway10.1016/j.biomaterials.2025.123507 ↗
42. Synthesis and Characterization of Types a and B Gelatin Methacryloyl for Bioink applications10.3390/ma9100797 ↗
43. Rational design of Core-Shell heterostructured CoFe@NiFe Prussian blue analogues for efficient capacitive deionization10.1016/j.cej.2024.150437 ↗
44. A Curcumin‐Modified Coordination Polymers with ROS Scavenging and Macrophage Phenotype Regulating Properties for Efficient Ulcerative Colitis Treatment10.1002/advs.202300601 ↗
45. Esterase-responsive kartogenin composite hydrogel microspheres boost nucleus pulposus regeneration in intervertebral disc degeneration10.1016/j.actbio.2025.04.001 ↗
46. Composite supramolecular hydrogel for osteoarthritis and cartilage repair enables localized and sustained drug delivery10.1016/j.matdes.2025.114066 ↗
47. Detection of serum anti-candidalysin IgG by indirect ELISA: a novel auxiliary tool for diagnosing invasive candidiasis in a preliminary pediatric study10.1128/spectrum.03245-24 ↗
48. Preserving the Immune‐Privileged Niche of the Nucleus Pulposus: Safeguarding Intervertebral Discs from Degeneration after Discectomy with Synthetic Mucin Hydrogel Injection10.1002/advs.202470260 ↗
49. The microspheres/hydrogels scaffolds based on the proteins, nucleic acids, or polysaccharides composite as carriers for tissue repair: a review
50. MMP-responsive hydrogel: a new approach for tissue repair and regeneration10.1016/j.matdes.2026.115573 ↗
51. IL-1ra loaded chondroitin sulfate-functionalized microspheres for minimally invasive treatment of intervertebral disc degeneration10.1016/j.actbio.2024.06.048 ↗
52. Extra Cellular Matrix Remodeling: an Adjunctive Target for Spinal Cord Injury and Intervertebral Disc Degeneration10.14245/ns.2244366.183 ↗
53. Extracellular matrix in intervertebral disc: basic and translational implications10.1007/s00441-022-03662-5 ↗
54. Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation10.1038/mi.2017.97 ↗
55. IL‐17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art10.1111/ijd.14695 ↗
56. Dual-controlled release of Mg2+/Zn2+ cage system promotes osteointegration in interbody fusion10.1016/j.matdes.2025.115045 ↗
57. A Salidroside‐Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X‐Ray Activated Synergistic Cancer Precise Therapy